Answers are grounded in this paper and cite their sources.
Androgen deprivation therapy (ADT) plays an important role in the treatment of advanced, recurrent, and metastatic prostate cancer (PCa). With increasing effectiveness of mono and combinatorial ADT therapies, patients with PCa are living longer lives, and in these older individuals, osteopenia due to ADT is a major cause of concern and morbidity. Studies conducted using the Surveillance, Epidemiology, and End Results (SEER)-Medicare program and the Prostate Cancer Outcomes Study have found a 1.2- to 2.5-fold increase in fracture risk after initiation of ADT.1-4 Currently, diagnosis of osteoporosis and estimation of fracture risk is performed using the dual-energy X-ray absorptiometry (DEXA) scan, which overestimates degree of osteoporosis and does not correlate well to clinical outcomes.5-8 Quantitative computed tomography (QCT) uses CT to volumetrically measure trabecular bone mineral density (BMD). It can be used in patients with metabolic diseases and obesity and allows for an accurate assessment of BMD, unlike DEXA where artifacts such as aortic calcifications and degenerative changes can confound results.9 While the dose of radiation in QCT is higher than DEXA, routine CT for staging is a part of the workup for high-risk PCa and this can provide a baseline assessment of BMD. In the present prospective study, the authors theorized that QCT would be more accurate than DEXA in estimating the amount of BMD loss from ADT.10 They found that patients with PCa who did not get ADT had a BMD loss of 8.5% over 1 year as compared with 17.5% in the ADT group. This incidence is much higher—for both ADT and non-ADT groups—than what has been reported for patients with PCa in prior studies using DEXA, which is between 2% and 13%.11 Does this mean QCT is a better imaging modality? Based on the limited data from this study, it does not seem so because these higher rates of osteoporosis on QCT did not correlate to higher/differential fracture rates—the ADT group had one new wrist fracture and the non-ADT group had one new L5 vertebral fracture during the study. Studies have shown that there is a correlation with DEXA based T-scores and QCT Hounsfield unit measurements, but at present, all guidelines are based on DEXA scan.12 QCT offers an alternative way to measure an important risk of ADT, as it can potentially assess BMD during CT or prostate specific membrane antigen (PSMA) CT scans, which can help integrate its use in PCa workup. However, before adoption of QCT into clinical workflow, much work needs to be done, including validation of the technology in larger prospective trials, demonstration of its relation to clinically valid outcomes, and its superiority over conventional methods.
No takes yet. Share an insight, caveat, or question.
Goradia et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: